Letter: Maintenance therapy in myeloma: risk versus benefit.
作者信息
Sieber S M, Adamson R H
出版信息
Br Med J. 1975 Jun 7;2(5970):557. doi: 10.1136/bmj.2.5970.557.
Abstract
摘要
相似文献
1
Letter: Maintenance therapy in myeloma: risk versus benefit.
Br Med J. 1975 Jun 7;2(5970):557. doi: 10.1136/bmj.2.5970.557.
2
Remission maintenance therapy for multiple myeloma.
Arch Intern Med. 1975 Jan;135(1):147-52.
3
Letter: Acute leukaemia and myeloma.
Lancet. 1974 Jun 1;1(7866):1113-4. doi: 10.1016/s0140-6736(74)90595-9.
4
[Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case].
Sem Hop. 1974 Jan 14;50(3):207-11.
5
A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy.
Nihon Ketsueki Gakkai Zasshi. 1974 Feb;37(1):49-57.
6
[Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Rinsho Ketsueki. 1984 Sep;25(9):1380-7.
7
Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol).
Oncology. 1985;42(3):137-40. doi: 10.1159/000226019.
8
[Acute myelogenous leukemia in myelomatosis].
Tidsskr Nor Laegeforen. 1977 Feb 10;97(4):175-7.
9
[Acute leukemia in a case of multiple myeloma].
Ned Tijdschr Geneeskd. 1973 Sep 29;117(39):1462-5.
10
[Leukemia in tumor patients receiving chemotherapy].
Dtsch Med Wochenschr. 1985 Sep 20;110(38):1439-41. doi: 10.1055/s-2008-1069024.
引用本文的文献
1
Risk-benefit analysis: from a logical point of view.
J Bioeth Inq. 2012 Jun;9(2):161-70. doi: 10.1007/s11673-012-9366-y. Epub 2012 Mar 21.
2
[Acute leukemia in multiple myeloma: case histories, a review of the literature and assessment of the incidence].
Klin Wochenschr. 1979 Aug 1;57(15):769-77. doi: 10.1007/BF01478035.
本文引用的文献
1
Extraosseous lesions in plasma cell myeloma. A report of six cases.
Am J Med. 1967 Aug;43(2):194-205. doi: 10.1016/0002-9343(67)90164-7.
2
Acute erythroleukaemia in a patient treated with melphalan for the cold agglutinin syndrome.
Scand J Haematol. 1971;8(5):375-9. doi: 10.1111/j.1600-0609.1971.tb00887.x.
3
Epidemic acute leukemia.
N Engl J Med. 1970 Nov 19;283(21):1165-6. doi: 10.1056/NEJM197011192832111.
4
Multiple myeloma and acute myelomonocytic leukemia.
N Engl J Med. 1970 Nov 19;283(21):1121-5. doi: 10.1056/NEJM197011192832101.
5
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.
J Exp Med. 1966 Nov 1;124(5):921-52. doi: 10.1084/jem.124.5.921.
6
[Macroglobulinemic reticulosis with leukemic end phase and loss of paraprotein].
Blut. 1970 Sep;21(3):137-45. doi: 10.1007/BF01675269.
7
Erythroleukaemia in a melphalan-treated patient with primary macroglobulinaemia.
Scand J Haematol. 1973;10(1):5-11. doi: 10.1111/j.1600-0609.1973.tb00031.x.
8
Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.
Am J Med. 1974 Dec;57(6):927-39. doi: 10.1016/0002-9343(74)90171-5.
9
Multiple myeloma and acute leukemia associated with alkylating agents.
Arch Intern Med. 1975 Jan;135(1):185-92.
Zotero 插件